glp-1 agonist and gastroparesis Researchers find medications safe to continue before surgery in patients with diabetes obesity Gastrointestinal Motility Effects of GLP-1
Description
This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare
This review delves into the physiological roles of GLP-1, exploring its impact on ...
Powered by Peptide
In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively
